Searched for
PRANDIN
Aurobindo Pharma gets USFDA nod for Repaglinide tabletsThe approval is for multiple strengths of the drug in 0.5mg, 1mg and 2mg. The product is ready for launch, the company said in a statement.- July-September Earnings: Sun Pharma has edge, but Cipla holds promiseSun Pharma’s exceptional performance was facilitated by strong showing in the US as well as the domestic market.
- Why Sun Pharma is likely to continue to be an outperformer in pharma sectorSun Pharma is the most valuable pharma stocks as the company is expected to post a strong performance in the quarters ahead.
- Dealing Room buzz: ACC, Sun Pharma, Cipla, Dish TVET Now spoke to dealers on institutional and high net worth investors’ activity in the dealing room. We bring you the stocks that were on t...
- Sun Pharma gains as subsidiary Taro inks drug pactElara Capital is of the view that current valuations of the company are rich and has maintained its ‘accumulate’ rating with target price o...
- Sun Pharma's stock vaults to 52-week high on Prandin approvalSun Pharma’s stock hit a 52-week high today on back of the company announcing of getting the US FDA approval for the generic Prandin.
- Morgan Stanley rates Sun Pharmaceutical Industries overweightMorgan Stanley has rated Sun Pharmaceutical Industries an 'overweight' after the US Supreme Court ruled in favor of Caraco in the Prandin c...
- Sun Pharmaceutical Industries gets favourable US Supreme Court verdict in patent caseSun Pharma said the US SC has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for trea...
Load More